Attached files
| file | filename |
|---|---|
| EX-99.1 - EX-99.1 - AVEO PHARMACEUTICALS, INC. | d368772dex991.htm |
| 8-K - FORM 8-K - AVEO PHARMACEUTICALS, INC. | d368772d8k.htm |
Exhibit 3.1
CERTIFICATE OF AMENDMENT
OF
RESTATED CERTIFICATE OF INCORPORATION
OF
AVEO PHARMACEUTICALS, INC.
AVEO Pharmaceuticals, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the “General Corporation Law”), does hereby certify as follows:
| 1. | The name of the Corporation is AVEO Pharmaceuticals, Inc. |
| 2. | Article FOURTH of the Restated Certificate of Incorporation of the Corporation, is hereby amended by replacing the first paragraph thereof with the following: |
“FOURTH: The total number of shares of all classes of stock which the Corporation shall have authority to issue is 255,000,000 shares, consisting of (i) 250,000,000 shares of Common Stock, $0.001 par value per share (“Common Stock”) and (ii) 5,000,000 shares of Preferred Stock, $0.001 par value per share (“Preferred Stock”).”
| 3. | This Certificate of Amendment has been duly adopted by the Board of Directors and stockholders of the Corporation in accordance with Section 242 of the General Corporation Law. |
* * *
IN WITNESS WHEREOF, the Corporation has caused its duly authorized officer to execute this Certificate of Amendment on this 26th day of June, 2017.
| AVEO PHARMACEUTICALS, INC. | ||
| By: | /s/ Michael Bailey | |
| Name: Title |
Michael Bailey President and Chief Executive Officer | |